Todd C Davis's Net Worth
$12.8 Million
Who is Todd C Davis?
Todd C Davis has an estimated net worth of $12.8 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, ARTES MEDICAL INC, LIGAND PHARMACEUTICALS INC, Vaxart, Inc., and Chromocell Therapeutics Corp.
SEC CIK
Todd C Davis's CIK is 0001392029
Past Insider Trading and Trends
2024 was Todd C Davis's most active year for acquiring shares with 10 total transactions. Todd C Davis's most active month to acquire stocks was the month of July. 2024 was Todd C Davis's most active year for disposing of shares, totalling 6 transactions. Todd C Davis's most active month to dispose stocks was the month of February. 2024 saw Todd C Davis paying a total of $1,323,876.55 for 341,168 shares, this is the most they've acquired in one year. In 2019 Todd C Davis cashed out on 218,123 shares for a total of $1,222,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIODELIVERY SCIENCES INTERNATIONAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -252.21K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
| +3.14% | 7.68K |
—
|
—
| 252.21K |
Jan 27
| |||
Form 4
| +13.98% | 30K |
—
|
—
| 244.52K |
Aug 6
| |||
Form 4
| -18.66% | -50.00K |
$4.99 | -$249,500.00 | 217.91K |
Aug 18
| |||
Form 4
| +12.61% | 30K |
—
|
—
| 267.91K |
Aug 7
| |||
Form 4
| -45.67% | -200.00K |
$6.11 | -$1,222,000.00 | 237.91K |
Nov 15
| |||
Form 4
| +4.32% | 18.12K |
—
|
—
| 437.91K |
Aug 13
| |||
Form 4
| +13,337.61% | 416.67K |
—
|
—
| 419.79K |
Aug 24
| |||
Form 4
|
∞
| 3.12K |
—
|
—
| 3.12K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARTES MEDICAL INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
LIGAND PHARMACEUTICALS INC (LGND) Snapshot price: $101.14
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.07% | 2.5K |
$97.39 | $243,480.50 | 123.01K |
Aug 8
| |||
Form 4
| +0.29% | 350 |
$60.71 | $21,247.45 | 120.51K |
Jun 28
| |||
Form 4
| +15.38% | 16.02K |
$57.39 | $919,147.00 | 120.16K |
Mar 25
| |||
Form 4
| +45.23% | 32.44K |
—
|
—
| 104.14K |
Feb 27
| |||
Form 4
| -1.89% | -1.38K |
$74.65 | -$103,091.65 | 71.71K |
Feb 15
| |||
Form 4
| +5.79% | 4K |
$59.38 | $237,528.80 | 73.09K |
Sep 22
| |||
Form 4
| -0.60% | -420.00 |
$73.76 | -$30,979.20 | 69.09K |
Jun 9
| |||
Form 4
| +32.84% | 17K |
—
|
—
| 68.79K |
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 5
| |||
Form 4
| +1.98% | 1K |
—
|
—
| 51.79K |
Jun 10
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4/A
|
∞
| 5K |
—
|
—
| 5K |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vaxart, Inc. (VXRT) Snapshot price: $0.88
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +6.22% | 7.38K |
—
|
—
| 125.91K |
Aug 4
| |||
Form 4
| -1.23% | -1.47K |
—
|
—
| 118.53K |
Dec 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
| -33.33% | -60.00K |
$3.28 | -$196,500.00 | 120K |
Apr 28
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Chromocell Therapeutics Corp (CHRO) Snapshot price: $0.898855
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
∞
| 29.17K |
$4.80 | $140,001.60 | 29.17K |
Feb 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||